In addition, HER2 has been validated as a prognostic and predictive factor in breast cancer (10), and there is growing evidence for a role of HER2 in GEC tumorigenesis, with studies frequently reporting HER2 amplification or overexpression in this tumor (6-, , 9). The gene discussed is ERBB2; the disease is breast carcinoma.